CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Kaerlev, Linda ^a,b   Iachina, Maria ^a,b   Pedersen, Jesper H ^c   Green, Anders ^a,b   Nørgård, Bente M ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Lung cancer; Psychosocial distress; Randomised trial; Screening

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; AGE; ANXIETY DISORDER; ARTICLE; CANCER REGISTRY; CANCER SCREENING; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DENMARK; FEMALE; FOLLOW UP; GENDER; HUMAN; LUNG CANCER; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHARMACY; PRESCRIPTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SOCIAL STATUS; THORAX RADIOGRAPHY;

ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY; COMORBIDITY; DEPRESSION; DRUG UTILIZATION; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; RISK; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861337535     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-188     Document Type: Article

References (24)

1. The National Lung Screening Trial Research Team Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011, 365:395-409. The National Lung Screening Trial Research Team.
2. van den Bergh KA, Essink-Bot ML, Bunge EM, Scholten ET, Prokop M, van Iersel CA, et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 2008, 113:396-404. 10.1002/cncr.23590, 18484588.
3. Brodersen J, Jorgensen KJ, Gotzsche PC. The benefits and harms of screening for cancer with a focus on breast screening. Pol Arch Med Wewn 2010, 120:89-94.
4. Bunge EM, van den Bergh KA, Essink-Bot ML, van Klaveren RJ, de Koning HJ. High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer. Lung Cancer 2008, 62:385-390. 10.1016/j.lungcan.2008.03.029, 18468717.
5. Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, et al. The Danish randomized lung cancer CT screening trial-overall design and results of the prevalence round. J Thorac Oncol 2009, 4:608-614. 10.1097/JTO.0b013e3181a0d98f, 19357536.
6. Hestbech MS, Siersma V, Dirksen A, Pedersen JH, Brodersen J. Participation bias in a randomised trial of screening for lung cancer. Lung Cancer 2011, 73:325-331. 10.1016/j.lungcan.2010.12.018, 21324544.
7. Ashraf H, Tonnesen P, Holst PJ, Dirksen A, Thorsen H, Dossing M. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009, 64:388-392. 10.1136/thx.2008.102475, 19052048.
8. Clark MM, Jett JR. Change in smoking status after low-dose spiral chest CT screening for lung cancer: opportunity for smoking intervention. Thorax 2009, 64:371-372. 10.1136/thx.2008.111039, 19401483.
9. Pieters MS, Jennekens-Schinkel A, Schoemaker HC, Cohen AF. Self-selection for personality variables among healthy volunteers. Br J Clin Pharmacol 1992, 33:101-106. 10.1111/j.1365-2125.1992.tb04007.x, 1381206, 1540478.
10. Ball CJ, McLaren PM, Morrison PJ. The personality structure of 'normal' volunteers. Br J Clin Pharmacol 1993, 36:369-371. 10.1111/j.1365-2125.1993.tb00379.x, 1364693, 12959318.
11. Almeida L, Kashdan TB, Nunes T, Coelho R, Albino-Teixeira A, Soares-da-Silva P. Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events. Eur J Clin Pharmacol 2008, 64:575-582. 10.1007/s00228-008-0468-8, 18320183.
12. Berto D, Milleri S, Squassante L, Baroldi PA. Evaluation of personality as a component of the healthy condition of volunteers participating in phase I studies. Eur J Clin Pharmacol 1996, 51:209-213. 10.1007/s002280050185, 9010686.
13. Bunce SC, Noblett KL, McCloskey MS, Coccaro EF. High prevalence of personality disorders among healthy volunteers for research: implications for control group bias. J Psychiatr Res 2005, 39:421-430. 10.1016/j.jpsychires.2004.09.005, 15804393.
14. Ashraf H, de HB, Shaker SB, Dirksen A, Bach KS, Hansen H, et al. Lung nodule volumetry: segmentation algorithms within the same software package cannot be used interchangeably. Eur Radiol 2010, 20:1878-1885. 10.1007/s00330-010-1749-z, 2899012, 20306082.
15. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011, 39:22-25. 10.1177/1403494810387965, 21775345.
16. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011, 39:30-33. 10.1177/1403494811401482, 21775347.
17. Statistics Denmark Statistics Denmark 2011, , , Statistics Denmark.
18. Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011, 39:38-41. 10.1177/1403494810394717, 21775349.
19. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
20. Iachina M, Green A, Jakobsen E. The impact of co-morbidity on survival of patients with non-small cell lung cancer: A joint model for survival and mixed-effect models with missing measurements in covariates. Unpublished Work 2011, : .
21. WHO Collaborating Centre for Drug Statistics Methodology ATC Index 2011, , , http://www.whocc.no/atc_ddd_index, WHO Collaborating Centre for Drug Statistics Methodology.
22. van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007, 120:868-874. 10.1002/ijc.22134, 17131307.
23. Baecke E, de Koning HJ, Otto SJ, van Iersel CA, van Klaveren RJ. Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON). Lung Cancer 2010, 69:66-70. 10.1016/j.lungcan.2009.08.015, 19801174.
24. Kaerlev L, Kolstad HA, Hansen AM, Thomsen JF, Kaergaard A, Rugulies R, et al. Are risk estimates biased in follow-up studies of psychosocial factors with low base-line participation?. BMC Public Health 2011, 11:539. 10.1186/1471-2458-11-539, 3146871, 21736760.